Senti Biosciences Holdings
SNTI
24 hedge funds and large institutions have $14.3M invested in Senti Biosciences Holdings in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.
0.03% more ownership
Funds ownership: 2.83% → 2.85% (+0.03%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less funds holding
Funds holding: 26 → 24 (-2)
14% less capital invested
Capital invested by funds: $16.6M → $14.3M (-$2.32M)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$427K |
| 2 |
TM
Triatomic Management
Palo Alto,
California
|
+$92.1K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$35.1K |
| 4 |
Citigroup
New York
|
+$22.5K |
| 5 |
CIBC Asset Management
Toronto,
Ontario, Canada
|
+$20.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$134K |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$37.9K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$33K |
| 4 |
Millennium Management
New York
|
-$32K |
| 5 |
Renaissance Technologies
New York
|
-$25K |
SNTI Hedge Fund Activity: Q1 2023 in Review
24 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Senti Biosciences Holdings (SNTI) for Q1 2023, worth a combined $14.3M — down 14% from $16.6M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of SNTI and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 3 added.
The largest buyer was NEA Management Company, adding an estimated $427K. The largest seller was T. Rowe Price Associates, cutting an estimated $134K.
- 24 institutional investors held Senti Biosciences Holdings (SNTI) as of Q1 2023, down from 26 in Q4 2022.
- Funds reported $14.3M of Senti Biosciences Holdings stock for Q1 2023, down 14% quarter-over-quarter.
- 2 funds opened new Senti Biosciences Holdings positions in Q1 2023 and 4 closed out, a net change of -2 holders.
- The largest Senti Biosciences Holdings buyer in Q1 2023 was NEA Management Company, an estimated $427K added.
- The largest Senti Biosciences Holdings seller in Q1 2023 was T. Rowe Price Associates, an estimated $134K sold.
Based on aggregated 13F filings for Q1 2023.